Mark R. Thomas

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Fish oil supplements in patients with chronic kidney disease.

Fish oil supplements in patients with chronic kidney disease.

Journal: Clinical kidney journal

Published: March 31, 2026

Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia.

Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia.

Journal: Journal of clinical medicine

Published: September 18, 2025

Assessing Cardiac Fitness for Kidney Transplantation - Uses and Pitfalls of Multimodality Imaging.

Assessing Cardiac Fitness for Kidney Transplantation - Uses and Pitfalls of Multimodality Imaging.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: September 11, 2025

Advanced Multipurpose Spectroscopic Nanobio-Device for Concurrent Lab-on-a-Chip Label-Free Separation and Detection of Extracellular Vesicles as Key-Biomarkers for Point-of-Care Cardiovascular Disease Diagnostics.

Advanced Multipurpose Spectroscopic Nanobio-Device for Concurrent Lab-on-a-Chip Label-Free Separation and Detection of Extracellular Vesicles as Key-Biomarkers for Point-of-Care Cardiovascular Disease Diagnostics.

Journal: Advanced healthcare materials

Published: January 08, 2025

Advanced biomolecular spectroscopic profiling of cardiovascular disease macromolecular markers: SIL-6, IL-9, LpA, ApoB, PCSK9 and NT-ProBNP for rapid in-situ detection and monitoring.

Advanced biomolecular spectroscopic profiling of cardiovascular disease macromolecular markers: SIL-6, IL-9, LpA, ApoB, PCSK9 and NT-ProBNP for rapid in-situ detection and monitoring.

Journal: International journal of biological macromolecules

Published: September 21, 2024

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice.

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice.

Journal: Blood advances

Published: January 19, 2024

GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease.

GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: December 14, 2023

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.

Journal: JAMA

Published: September 11, 2023

Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction.

Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction.

Journal: Frontiers in molecular biosciences

Published: September 01, 2023

Modelling clinical narrative as computable knowledge: The NICE computable implementation guidance project.

Modelling clinical narrative as computable knowledge: The NICE computable implementation guidance project.

Journal: Learning health systems

Published: May 16, 2023

Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.

Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 22, 2023

Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes.

Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes.

Journal: Vascular pharmacology

Published: October 31, 2022

Showing 1-12 of 74

Last Updated: 09/26/2026